Seeking Alpha

PETX
  Aratana Therapeutics - NASDAQ

11/22/2014, 4:12 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
PETX vs. ETF Alternatives
Company Description
Aratana Therapeutics Inc is a development-stage biopharmaceutical company. It is engaged in licensing, development and commercialization of prescription medicines for pets.
Sector: Healthcare
Industry: Biotechnology
Country: United States